The pharmaceutical landscape is undergoing a revolution with the emergence of novel glucagon-like peptide-1 (GLP-1) receptor agonists. These innovative drugs demonstrate immense potential in managing type 2 diabetes https://lawsonbuxf786031.blogprodesign.com/57175917/novel-glp-1-receptor-agonists-retatrutide-cagrillintide-tirzepatide-and-semaglutide